Galectin Therapeutics Inc. financial statements
Galectin Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 30.84M | 10-K |
| Cash and equivalents | USD 17.72M | 10-Q |
| Total debt | USD 133.76M | EODHD |
Galectin Therapeutics Inc. financials on 6ix · Galectin Therapeutics Inc. on 6ix